Company profile

Ticker
TFX
Exchange
CEO
Liam J. Kelly
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
231147939

TFX stock data

(
)

Calendar

1 Aug 19
22 Sep 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Jun 19 Mar 19 Dec 18 Sep 18
Revenue 652.51M 613.58M 641.62M 609.67M
Net income 90.59M 56.52M
Diluted EPS 1.77 0.87 1.93 1.21
Net profit margin 14.12% 9.27%
Operating income 107.46M 75.24M 119.27M 82.11M
Net change in cash 32.68M -85.95M 885K 9.97M
Cash on hand 303.9M 271.21M 357.16M 356.28M
Cost of revenue 279.58M 268.84M 275.79M 267.1M
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 2.45B 2.15B 1.87B 1.81B
Net income 200.8M 152.53M 237.38M 244.86M
Diluted EPS 4.29 3.27 4.98 5.1
Net profit margin 8.20% 7.11% 12.71% 13.53%
Operating income 321.7M 372.28M 319.45M 315.89M
Net change in cash 23.6M -210.23M 205.42M 35.13M
Cash on hand 357.16M 333.56M 543.79M 338.37M
Cost of revenue 1.06B 974.5M 871.83M 865.29M

Financial data from Teleflex earnings reports

Financial report summary

?
Management Discussion
  • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  • All statements made in this Quarterly Report on Form 10-Q, other than statements of historical fact, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “will,” “would,” “should,” “guidance,” “potential,” “continue,” “project,” “forecast,” “confident,” “prospects” and similar expressions typically are used to identify forward-looking statements. Forward-looking statements are based on the then-current expectations, beliefs, assumptions, estimates and forecasts about our business and the industry and markets in which we operate. These statements are not guarantees of future performance and are subject to risks and uncertainties, which are difficult to predict. Therefore, actual outcomes and results may differ materially from those expressed or implied by these forward-looking statements due to a number of factors, including changes in business relationships with and purchases by or from major customers or suppliers; delays or cancellations of shipments; demand for and market acceptance of new and existing products; our inability to provide products to our customers, which may be due to, among other things, events that impact key distributors; our inability to integrate acquired businesses into our operations, realize planned synergies and operate such businesses profitably in accordance with our expectations; our inability to effectively execute our restructuring plans and programs; our inability to realize anticipated savings from restructuring plans and programs; the impact of enacted healthcare reform legislation and proposals to amend, replace or repeal the legislation; changes in Medicare, Medicaid and third party coverage and reimbursements; the impact of tax legislation and related regulations; competitive market conditions and resulting effects on revenues and pricing; increases in raw material costs that cannot be recovered in product pricing; global economic factors, including currency exchange rates, interest rates, trade disputes, sovereign debt issues and the impact of the United Kingdom’s pending departure from the European Union, commonly known as "Brexit"; difficulties in entering new markets; and general economic conditions. For a further discussion of the risks relating to our business, see Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2018. We expressly disclaim any obligation to update these forward-looking statements, except as otherwise specifically stated by us or as required by law or regulation.
  • Teleflex is a global provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We market and sell our products worldwide through a combination of our direct sales force and distributors. Because our products are used in numerous markets and for a variety of procedures, we are not dependent upon any one end-market or procedure. We are focused on achieving consistent, sustainable and profitable growth by increasing our market share and improving our operating efficiencies.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: anniversary, automatically, content, entry, inflation, key, life, longer, main, removal, removed, Supplemental
Removed: entitled, large, remain, return